we specialize on
Cross-border Projects
We provide comprehensive advisory services targeting the flourishing biopharma industries including market assessment, in/out-licensing, capital raising, joint ventures, and clinical trial management. We strive to help Western pharma/biotech companies to:
Navigate the complexities of the global-regional market through decades of knowledge and experience;
Develop strategies to secure partnership/investment in global-regional through intimate understanding of the industry and local market;
Be always prepared but creative and bold when necessary, and be rewarded with opportunities in an enormous market and the satisfaction of helping millions of patients.
many advisory firms to choose from,
Why MSQ?
Focusing on the global-regional healthcare industry, our platform combines the strengths of our dedicated US based research team, cross-border transaction execution team and senior advisory team, with the resources of a large Global-regional network of investors and industry leaders, KOLs and government regulatory agencies. Internally, we value teamwork, integrity, professionalism, and always go above and beyond to ensure our clients’ success. With MSQ, you can count on the Three Pillars of MSQ Service:
Cross-border focus with global-regional insight;
Team work with expertise in the healthcare industry;
Proven systematic process.
We are here
Bridging West & East
Helping find a cure for every disease
We give you
The MSQ Guarantee
We are a trusted partner.
We deliver timely results.
We go above and beyond.
Find out more about our Team:
but Don’t listen to us
Listen to our clients
“MSQ Ventures, with their expertise and broad connections in China healthcare industry, demonstrates great professionalism and outstanding performance during all the collaborations with us. MSQ team worked closely with us and completed high-quality deliverables on time with acute attention to our needs.”
“MSQ provided key insights and informative interviews from KOLs in the research report, helping us to clarify our strategic goals in the Chinese market. MSQ team worked closely with us and completed high-quality deliverables on time with attention to our needs.”
“The Tier 1 strategic investors MSQ Ventures introduced were of the highest professional quality. The majority of the investors were knowledgeable and well-prepared. They understood our underlying technology and core competencies in short order, which differentiates MSQ Venture’s network in China from other firms.”
“MSQ Ventures’ insights into China’s healthcare industry was invaluable in enabling my team, and I, to evaluate, accurately, the enormous opportunities, within OBT’s therapeutic space, in China. MSQ’s custom-tailored research and meticulous approach helped my team and I achieve a deeper understanding of the Chinese biotech landscape, and effectively establish high-quality partnerships with active biotech investors and biopharma partners within a very short amount of time. ”